Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / MEDXF - Medexus: Commercial And Late-Stage Rare Disease Pharmaceuticals

MEDXF - Medexus: Commercial And Late-Stage Rare Disease Pharmaceuticals

Medexus Pharmaceuticals Inc
  • Medexus has a well established sales force and infrastructure for commercializing pharmaceutical prescription and OTC products.
  • The Company faced a setback for the launch of treosulfan in the US as its licensor received CRL.
  • The Company missed on revenue guidance for the first quarter of its FY-2022.

For further details see:

Medexus: Commercial And Late-Stage Rare Disease Pharmaceuticals
Stock Information
Company Name: Medexus Pharmaceuticals Inc
Stock Symbol: MEDXF
Market: OTC
Website: medexusinc.com
Menu
MEDXF MEDXF Quote MEDXF Short MEDXF News MEDXF Articles MEDXF Message Board
Get MEDXF Alerts

News, Short Squeeze, Breakout and More Instantly...